Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jason Alexander Efstathiou"'
Autor:
Daniel J. Krauss, Theodore Karrison, Alvaro A. Martinez, Gerard Morton, Di Yan, Deborah Watkins Bruner, Benjamin Movsas, Mohamed Elshaikh, Deborah Citrin, Bruce Hershatter, Jeff M. Michalski, Jason Alexander Efstathiou, Adam Currey, Vivek S. Kavadi, Fabio L. Cury, Michael Lock, Adam Raben, Samantha Andrews Seaward, Ali El-Gayed, Joseph P. Rodgers, Howard M. Sandler
Publikováno v:
Journal of Clinical Oncology.
PURPOSE It remains unknown whether or not short-term androgen deprivation (STAD) improves survival among men with intermediate-risk prostate cancer (IRPC) treated with dose-escalated radiotherapy (RT). METHODS The NRG Oncology/Radiation Therapy Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80e1d5d47a6aab706554edc6f8e4f298
https://doi.org/10.1200/jco.22.02390
https://doi.org/10.1200/jco.22.02390
Autor:
Ayal Aizer, Jonathan J. Paly, Anthony L. Zietman, Anthony Victor D'Amico, Paul Linh Nguyen, Clair Beard, Sandhya K Rao, Irving D. Kaplan, Michelle S. Hirsch, Chin-Lee Wu, Jason Alexander Efstathiou
Publikováno v:
Journal of Clinical Oncology. 30:131-131
131 Background: Factors associated with pursuit of active surveillance in men with low-risk prostate cancer are not well-delineated. Methods: 701 patients with low-risk prostate cancer (clinical stage < T2b, Gleason score < 7, and PSA < 10 ng/mL), tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53a65c1132896dc0155c82da5cd31176
https://doi.org/10.1200/jco.2012.30.5_suppl.131
https://doi.org/10.1200/jco.2012.30.5_suppl.131